Paper Details

  1. Home
  2. Paper Details

Single-dose cefotetan for urinary tract infection.

Author: SandersonP J

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Cefotetan (2 g IM) was effective in treating lower urinary tract infection in 7 patients. Minor side effects were reported in two patients.
Paper Details　
Original Abstract of the Article :
Seven female patients with lower urinary tract infection were treated with a single 2 g intramuscular dose of cefotetan. Six patients were clinically cured when seen 1 week after treatment and 5 patients remained well at 4 weeks after treatment. One patient developed loose stools and a vulval rash, ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/3906676

データ提供：米国国立医学図書館（NLM）

A Camel's Perspective on Single-Dose Cefotetan for Urinary Tract Infections: A Streamlined Approach

Urinary tract infections (UTIs), a common ailment, can be a source of discomfort and distress. This study investigates the efficacy of a single intramuscular dose of cefotetan for the treatment of lower UTIs. The authors evaluated the clinical response and side effects of this single-dose regimen in a small group of female patients. The study found that a single 2g dose of cefotetan resulted in clinical cure in most patients, suggesting that this streamlined approach could be a viable option for treating UTIs. However, the study also noted some side effects, including loose stools and a vulval rash, highlighting the need for further investigation and careful patient monitoring.

Seeking a More Efficient Oasis in the Desert of UTI Treatment

This study explores a potential oasis in the desert of UTI treatment, examining the efficacy of a single-dose cefotetan regimen. The study's findings suggest that this streamlined approach could be a viable option for treating UTIs, but it also underscores the need for further research and careful patient monitoring.

Navigating the Desert of UTI Treatment: A Camel's Guide

The management of UTIs requires a balance between efficacy and safety. This study underscores the need for continued research and development of effective and well-tolerated treatment regimens. It is like finding a reliable oasis in the desert of UTI treatment, offering a safe and effective path to recovery.

Dr.Camel's Conclusion

This research provides valuable insights into the potential of single-dose cefotetan for the treatment of lower UTIs. The study's findings highlight the need for further research and careful patient monitoring to optimize the safety and efficacy of this regimen. Ultimately, the goal is to find a reliable oasis in the desert of UTI treatment, offering patients a safe and effective path to recovery.

Date :
  1. Date Completed 1985-12-30
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

3906676

DOI: Digital Object Identifier

3906676

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.